Skyview Ventures

SilkTech Biopharmaceuticals’ IND Submission Cleared by FDA; Phase 2 Clinical Trial Initiated for Patients with Dry Eye Disease

Milestone Results in $6.2 Million in Additional VC Funding Minneapolis, MN – April 16, 2019 – PRWeb – SilkTech Biopharmaceuticals, a company devoted to improving eye health through the development of silk-derived protein biotherapeutics for the targeted treatment of Dry Eye Disease (DED), today announced the company has received clearance of its Investigational New Drug […]

November 30, 2017: In the Know

Genetic Markers in Advanced Prostate Cancer Could Explain Treatment Resistance This Cancer Survivor’s Startup Wants to Take the Danger out of Drug Testing Skyview Ventures Makes Significant Investment in Silk Technologies, Ltd. Takeda moves ahead in Zika race with launch of vaccine trial MGC Diagnostics Corporation Agrees To Be Acquired By Altus Capital Partners Medtronic […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER